韩国裸舞

Only about 1 in 20 cancer patients participates in trials of experimental therapies. Doctors and drugmakers should be prudent about continuing to test products in desperate, hard-to-find patients when they haven鈥檛 shown significant benefits in multiple earlier studies, said Jonathan Kimmelman, a biomedical ethicist at 韩国裸舞 in Montreal.

鈥淵ou have a ridiculous number of drugs and targets and combinations you can test,鈥� said Kimmelman, director of the Studies of Translation, Ethics and Medicine research group. 鈥淵ou want to pull the weeds and take the drugs and combinations that have the best prospects.鈥�